Summit Therapeutics
SMMT
#1192
Rank
NZ$26.68 B
Marketcap
$36.17
Share price
8.23%
Change (1 day)
394.44%
Change (1 year)

EPS for Summit Therapeutics (SMMT)

EPS in 2023 (TTM): -$2.70

According to Summit Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.93. In 2022 the company made an earnings per share (EPS) of -$0.87 an increase over its 2021 EPS that were of -$1.67.

EPS history for Summit Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.70209.52%
2022-$0.87-47.8%
2021-$1.67
2019-$0.37159.55%
2018-$0.14
2015-$1.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$13.64 365.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.19-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.78 97.49%๐Ÿ‡บ๐Ÿ‡ธ USA